key: cord-0878729-hq22qlfi authors: Phyo, Zaw Hlyan; Harris, Che Matthew; Singh, Amteshwar; Kotwal, Susrutha title: Utility of a Diagnostic Time-out to Evaluate an Atypical Pneumonia date: 2021-11-20 journal: Am J Med DOI: 10.1016/j.amjmed.2021.10.028 sha: 191f2d7be3d07dc3470771c09df99da55a366007 doc_id: 878729 cord_uid: hq22qlfi nan A 48-year-old woman with no significant medical history presented to the emergency department with fever, non-productive cough, and shortness of breath for four days. She reported ongoing dyspnea on exertion over one month which rapidly progressed in the days leading up to her presentation. In the past month, she reported experiencing watery, non-bloody diarrhea, night sweats, and ageusia. Review of system was negative for weight loss, headache/neck pain, chest pain, rash, lymphadenopathy, arthralgia, dysuria and change in urinary frequency. The patient worked as a meat cutter at a local grocery store in Maryland and did not report any sick contacts, recent travel, or illicit substance use. Her vaccinations were up to date including the COVID-19 vaccine, which she received two months prior to presentation. She was febrile (temperature 38.1C), tachypneic with oxygen saturation of 88% and tachycardic (heart rate 117 beats/min, blood pressure 106/71 mm Hg). Pulmonary exam was notable for diffuse, coarse crackles bilaterally and she was in respiratory distress (respiratory rate 20 breaths/min) requiring 2 liters of supplemental oxygen. Wheezing, intercostal retractions or fingernail clubbing were absent. Her complete blood count showed hemoglobin of 9.9 g/dL (reference 12-16 g/dL) and normal white blood cell count with neutrophilia (83.6%, reference 40%-60%) and lymphopenia (5.5%, reference 20%-40%) [ Table 1 ]. Serum electrolytes, liver enzymes, blood urea nitrogen and creatinine were within normal limits. Inflammatory markers such as c-reactive protein (14.6 mg/dL, reference < 10 mg/dL) and erythrocyte sedimentation rate (114 mm/h, reference < 29 mm/h) were elevated, and COVID-19 nasal swab was negative. Chest x-ray demonstrated prominent central broncho-vascular markings ( Figure 1A ). Computed tomography scan without contrast of the thorax revealed diffuse, symmetric bilateral ground-Diagnostic time-out glass opacities most prominent at the lung bases ( Figure 1B) . Given that the presentation was most consistent with community-acquired viral or atypical pneumonia, she was admitted to the hospital and initiated on intravenous antibiotics for pneumonia. The diagnostic workup included two sets of peripheral blood cultures, sputum culture, Streptococcus pneumoniae and Legionella bacterium urine antigen and a comprehensive respiratory virus panel test (including a repeat SARS-CoV-19), all of which were negative. After two days, her fevers persisted with a maximum temperature of 39.4C, and her clinical status deteriorated with progressive fatigue, intermittent episodes of confusion, and increasing oxygen requirement up to 6 liters. A repeat computed tomography scan of her lungs to evaluate for pulmonary embolism and progression of pneumonia revealed worsening lung opacities but no evidence of pulmonary embolism ( Figure 1B ). The initial diagnosis of pneumonia seemed an adequate fit given the opacities on chest imaging and the clinical syndrome that included fever, dyspnea and cough. 1 Her history of extrapulmonary symptoms (diarrhea, night sweats, ageusia) suggested an atypical pneumonia. Due to the current pandemic, we were most suspicious of COVID-19 pneumonia, however this was ruled out by two polymerase chain reaction tests performed a day apart. The patient's worsening status then prompted a diagnostic time-out, and reevaluation of her history, which revealed that her husband was HIV positive and non-adherent to antiretroviral therapy. Subsequently, a hypothesis driven physical exam revealed pseudomembranous, white patches on the tongue most consistent with oral candidiasis (Figure 2 ) driving us to consider immunocompromised states in our differential diagnosis. The HIV polymerase chain reaction Diagnostic time-out test returned positive with a CD4 count of 7 (normal 500-1200 cells per cubic millimeter, cells/mm 3 ) and a lactate dehydrogenase level that was elevated [ Table 1 ]. Diagnosis of Pneumocystis jirovecii pneumonia was confirmed by bronchoscopy with bronchoalveolar lavage, which is the gold-standard diagnostic test (sensitivity of 90-98% and specificity of 83-96%). 2 Given an acute change in the patient's mental status, lumbar puncture and head imaging were also performed to rule out meningoencephalitis. Brain magnetic resonance imaging revealed non-specific, diffuse ischemic changes and lumbar puncture was negative for infection in the cerebrospinal fluid. Pneumocystis jirovecii which typically occurs in immunocompromised individuals and remains a prevalent opportunistic infection in HIV-infected individuals, comprising 20% of pulmonary infiltrates of infectious etiology. 2 Other risk factors for this opportunistic infection include malignancy, hematopoietic stem cell or solid organ transplantation, and medications such as glucocorticoids or immunosuppressive therapies (e.g. cyclosporine). 3 Pneumocystis is thought to be transmitted via airborne droplets. Immunocompetent individuals, while typically not affected, may serve as reservoirs for spread to immunocompromised hosts. 4 Pneumocystis jirovecii pneumonia in an HIV-infected individual commonly presents with progressive dyspnea in the setting of fever and non-productive cough. It typically appears on chest radiograph as bilateral perihilar interstitial infiltrates (referred to as "ground-glass opacities"). Detection of Pneumocystis jirovecii on bronchoalveolar lavage is the gold-standard for diagnosis and provides the highest diagnostic yield in infected individuals. 5 Trimethoprim-Sulfamethoxazole (TMP-SMX) is the most effective treatment for Pneumocystis jirovecii pneumonia 4 ; the adjunctive use of corticosteroids reduces mortality and the need for mechanical Diagnostic time-out ventilation in patients with hypoxemia (partial pressure of arterial oxygen less than 70 mm Hg or alveolar-arterial gradient above 35). 6 Utility of diagnostic time-out: According to the dual process theory of decision making, physicians rely on two types of reasoning models, analytic and intuitive, in diagnosis and management of patients. 7 In the analytic model, physicians employ a time-consuming process in generating broad differential diagnosis and a deliberate evaluation of hypotheses. In contrast, the intuitive model relies on pattern-recognition refined by knowledge of typical/atypical presentations and clinical experience. Through this case report, we offer an approach to improve the diagnostic process by utilizing a diagnostic time-out ( Figure 3 ). This approach enables the clinician to reflect on potential gaps in data gathering, the impact of cognitive biases, and embarking on plans with structured follow-ups. 8 Returning to the bedside to gather a hypothesis-driven history and perform a comprehensive exam may prompt discovery of key findings, as illustrated by the patient's oropharyngeal candidiasis and a history of HIV infection in her spouse. The patient was initiated on a 21-day course of oral TMP-SMX (800mg trimethoprim, 160mg sulfamethoxazole) twice a day and prednisone taper in addition to anti-retroviral therapy in accordance with current Centers for Disease Control and prevention guidelines for patients with CD4 count less than 200 cells/mm 3 . 9 Two weeks after discharge at a follow-up appointment with her primary care provider, she reported resolution of symptoms and adherence to antiretroviral therapy. Table 1 : Pertinent laboratory values including the complete blood count, complete metabolic profile, and inflammatory markers, measured at presentation and date of discharge. Diagnosis and Treatment of Adults with Communityacquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America Pulmonary infections in HIV-infected patients: an update in the 21st century Opportunistic Infections in Patients with and Patients without Acquired Immunodeficiency Syndrome Pneumocystis Pneumonia Pneumocystis carinii Pneumonia: Differences in Lung Parasite Number and Inflammation in Patients with and without AIDS Corticosteroids as Adjunctive Therapy for Severe Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome THE NATIONAL ACADEMIES PRESS Improving Diagnosis in Health Care Checklists to reduce diagnostic errors